Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study).
Schokker S, van der Woude SO, van Kleef JJ, van Zoen DJ, van Oijen MGH, Mearadji B, Beenen LFM, Stroes CI, Waasdorp C, Jibodh RA, Creemers A, Meijer SL, Hooijer GKJ, Punt CJA, Bijlsma MF, van Laarhoven HWM.
Schokker S, et al. Among authors: van oijen mgh, van kleef jj, van zoen dj, van laarhoven hwm, van der woude so.
Cancers (Basel). 2019 Jun 14;11(6):827. doi: 10.3390/cancers11060827.
Cancers (Basel). 2019.
PMID: 31207904
Free PMC article.